BERLIN, May 26, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

The Indian patent, granted in a pharmaceutical market estimated at US $55 billion (Bain & Company) complements Innocan's global patent applications, strengthening the proprietary value of its ...

TME Pharma N.V. (Euronext Growth Paris: ALTME),a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

The Company is hereby clarifying and providing additional information on the financing announced on May 21, 2025 TME Pharma has secured private binding commitments from professional European ...

Silo Pharma Inc. + Watchlist Alert SILO US Open Last Updated: Jun 5, 2025 12:09 p.m. EDT Real time quote $ 0.6164 0.0454 7.95% Previous Close $0.5710 Toggle Chart Options Advanced Charting ...

Henan Lingrui Pharmaceutical Co. Ltd. A 0.04% ¥13.2B Apeloa Pharmaceutical Co. Ltd. A-0.66% ¥16.05B Shanghai Fosun Pharmaceutical (Group) Co. Ltd. A-0.17% ¥57.36B Shanghai Shyndec Pharmaceutica ...

(Reuters) -Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses.

The rise in non-prescribed ketamine use across the UK in recent years is a cause for concern, say doctors in The BMJ today. A landmark global modeling study reveals that more than 2.8 billion ...

Melbourne Pharma Logo Mike Boehmer, Lead Pharmacist Robert Robinson, Non-Sterile Lab Manager Melbourne Pharma offers expert, custom dermatology compounding for Florida patients—led by pharmacist Mike.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.